2 completed, 1 not yet recruiting, 1 unknown. 3 Phase 3, 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Not yet recruiting 1 |
| Not applicable | 1 | Unknown 1 |
| Phase 2 | 1 | Completed 1 |
Follow Asymptomatic Malaria: new trials by email Literature Review of Asymptomatic Malaria trials Research Report on Asymptomatic Malaria
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| OPTIMAL LEAP: Optimizing Dihydroartemisinin-Piperaquine IPTsc Intervals to Advance Learning, Executive Function, Attendance, and Antimalarial Resistance Surveillance in Kenyan Schoolchildren Monthly DP, Quarterly DP - Malaria, Asymptomatic Malaria | Phase 3 | Not yet recruiting | Indiana University | 1500 | 2028-01-01 | 2026-09-01 |
| Emptying Malaria Reservoirs to Accelerate Malaria Elimination in High Transmission Settings Artemisia afra tea infusions, Flavored placebo infusions, Regular tea placebo - Asymptomatic Malaria | Not applicable | Unknown | Université Catholique de Louvain | 112 | 2023-04-01 | 2022-07-01 |
| Dihydroartemisinin-piperaquine With Low Dose Primaquine to Reduce Malaria Transmission Dihydroartemisinin-piperaquine combination (Artekin), Primaquine - Malaria, Asymptomatic Malaria | Phase 3 | Completed | London School of Hygiene and Tropical Medicine | 120 | 2014-10-01 | 2016-01-14 |
| Low Dose Primaquine for Clearance of Gametocytes Artemether-lumefantrine combination, Artemether-Lumefantrine with a single dose of 0.25mg/kg primaquine, Artemether-Lumefantrine with a single dose of 0.4mg/kg primaquine - Malaria, Asymptomatic Malaria | Phase 2 / Phase 3 | Completed | London School of Hygiene and Tropical Medicine | 360 | 2013-09-01 | 2015-09-02 |
Malaria (3) · Malaria, Falciparum (3) · Anemia (1) · Inflammation (1) · Literacy (1)
Infections (3) · Mosquito-Borne Diseases (3) · Parasitic Diseases (3) · Protozoan Infections (3) · Vector Borne Diseases (3) · Behavior (1) · Communication (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Primaquine (2) · Artemether, Lumefantrine Drug Combination (1)
London School of Hygiene and Tropical Medicine (2) · Indiana University (1) · Université Catholique de Louvain (1)
Burkina Faso (1) · Kenya (1)
Alfred Tiono, PhD, MD (1) · Eren Oyungu, MBChB, MMED (1) · Frederick Michel, Professor (1) · Ghogomu Stephen, Professor (1) · Megan S McHenry, MD, MS (1) · Patrick Sawa, MD (1) · Robert Annie, Professor (1) · Souopgui Jacob, Professor (1) · Suh Nchang Abenwie, MSc. MPH (1) · Teun Bousema, PhD (1)